- Home
- OSK vs RGC Comparison
OSK vs RGC Comparison
Compare OSK & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OSK | RGC |
|---|---|---|
| Founded | 1917 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 9.8B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | OSK | RGC |
|---|---|---|
| Price | $172.22 | $28.12 |
| Analyst Decision | Buy | |
| Analyst Count | 14 | 0 |
| Target Price | ★ $156.71 | N/A |
| AVG Volume (30 Days) | ★ 936.3K | 677.3K |
| Earning Date | 01-29-2026 | 10-31-2025 |
| Dividend Yield | ★ 1.40% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 10.02 | N/A |
| Revenue | ★ $10,422,300,000.00 | N/A |
| Revenue This Year | $5.91 | N/A |
| Revenue Next Year | $6.89 | N/A |
| P/E Ratio | $16.32 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $76.82 | $0.09 |
| 52 Week High | $169.62 | $83.60 |
Technical Indicators
Market Signals| Indicator | OSK | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 68.43 | 48.11 |
| Support Level | $136.55 | $24.62 |
| Resistance Level | $169.62 | $29.00 |
| Average True Range (ATR) | 6.30 | 4.72 |
| MACD | 0.93 | -0.94 |
| Stochastic Oscillator | 87.63 | 33.17 |
Price Performance
Historical ComparisonAbout OSK Oshkosh Corporation
Oshkosh is a leading maker of access equipment, specialty vehicles, and military trucks. It serves diverse end markets, including postal, firefighting, refuse/recycling collection, aviation, and construction. It is typically the market share leader or No. 2 player in North America, or even the global leader in the case of its JLG aerial work platform business. The transport segment is a leading provider of light trucks to the military and vehicles to the Postal Service. The vocational segment, featuring brands such as Pierce, AeroTech, and Volterra, offers purpose-built vehicles and equipment to municipalities. The company reports three segments—Access equipment (49% of revenue), Vocational (31%), and Transport (20%) on 2024 revenue of $10.7 billion.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.